LIMITED STAGE SMALL-CELL LUNG CANCER
Clinical trials for LIMITED STAGE SMALL-CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new LIMITED STAGE SMALL-CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for LIMITED STAGE SMALL-CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to control tough lung cancer
Disease control Not yet recruitingThis study tests whether adding the immunotherapy drug adebrelimab to standard chemoradiotherapy can help control limited-stage small-cell lung cancer. About 30 adults aged 18-75 will receive the combination, then continue adebrelimab alone. The goal is to see if the treatment de…
Matched conditions: LIMITED STAGE SMALL-CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Peking University Cancer Hospital & Institute • Aim: Disease control
Last updated May 17, 2026 02:04 UTC
-
New drug aims to shield cancer patients from chemo side effects
Disease control Not yet recruitingThis trial tests if trilaciclib can protect the bone marrow in people with limited-stage small cell lung cancer who are getting chemotherapy. About 120 participants will receive either trilaciclib or a placebo. The goal is to see if the drug reduces severe low white blood cell co…
Matched conditions: LIMITED STAGE SMALL-CELL LUNG CANCER
Phase: PHASE3 • Sponsor: Pharmacosmos A/S • Aim: Disease control
Last updated May 17, 2026 02:03 UTC